(2 customer reviews)

Thrive – Mushroom Immune Complex

Immune Stimulator
Optimize Immune Function
Helps improve gut immunity

Quantity Discount – Choose:

How Subscription Works:
– Our subscription program lets you replenish your favorite products without the trouble of remembering to reorder. It’s convenient, affordable and easy.
– By purchasing this subscription we will auto ship you every 1, 3, or 6 months depending on your order details. Once on auto ship you’ll enjoy our highest VIP Customer savings as long as your enrolled.
– We’ll NOTIFY you via email 5 days BEFORE each shipment, so you can pause, skip, or modify your subscription options. Nothing could be easier!
-Subscriptions purchased to receive the price discount you are agreeing to be automatically billed at least 1 consecutive re-order before any cancellation can be made.

Ships Immediately.

SKU: THRIVE1 Categories: ,
 

Description

Optimal immune response is crucial during this viral season!

Thrive; Mushroom Immune Defense combines ten of the world’s most potent medicinal mushrooms. This synergistic blend balances the body’s immune system in response to viruses, bacteria and other harmful pathogens, by promoting innate and acquired immune cells. Our combination of concentrated fruiting body extracts contains more bioactive levels of beta-glucans which provides effective immune modulation, and are linked to anticancerous, cardioprotective, hepatoprotective, antioxidative and antimicrobial activity. The Thrive blend is also rich in potent anti-inflammatory adaptogens known to boost immune system performance through their phytochemical constituents. Our elevated concentrations of polysaccharides, triterpenoids, sterols, prebiotics, antioxidant enzymes, amino acids, polyphenols, proteins, peptides, flavonoids, and digestive enzymes make this combination a powerhouse for daily immune and full body support.

Product Details:

Product: THRIVE | Mushroom Complex
Ingredients: Cordyceps Sinensis powder
Reishi Mushroom Extract
Shitake Mushroom Extract
Lions Mane
Maitake, Turkey Tail, Changa, Royal Sun Agaricus, White Button, Black Fungus

One serving size is 2 veggie capsule
Servings Per Bottle: 60 capsules

Nutritional Facts:

Cordyceps Sinensis powder: 266mg
Reishi Mushroom Extract: 266mg
Shitake Mushroom Extract: 266mg
Lions Mane: 266mg
Proprietary Blend: Maitake, Turkey Tail, Changa, Royal Sun Agaricus, White Button, Black Fungus: 266mg

FREE With Every Order

Cooking Slim Cookbook (A $49.99 Value)

Enjoy our world-class Gluten-Free Weight Loss Cookbook. It’s so easy…and delicioius…that your family won’t even know they’re eating ‘health food’ when you serve these delicious appetizers, meals, drinks, and desserts.

100 Pages, over 60 Recipes 100% Gluten Free

INCLUDES: Special Bonus Research Reports on the best food tricks for weight loss. (Digital Download)

Basic Essentials (A $39.99 Value)

Carry these 7 short manuals with you on your phone, iPad, computer, or print them up at home and take to the gym. But don’t worry – you don’t need ANY equipment because these powerful exercises are meant to perform anywhere, anytime, with no gadgets or pricey equipment. These are some of the world’s fastest, easiest, and most powerful exercises that you can combine with daily Wu-Long or SlimTea to rev your metabolism, look great, and feel like you’re a teenager again. (Digital Download)

Extended Description

Details:
In recent years, there has been a significant increase in the consumption of medicinal mushroom due to an increasing number of studies identifying the therapeutic properties from various species.
Medicinal mushrooms have a notoriously high antioxidant concentration. These compounds combat oxidative stress in your body, which gives rise to inflammation and ultimately to a wide range of diseases. Specifically, medicinal mushrooms contain powerful polyphenol antioxidants. A diet high in polyphenols is associated with a lower risk of cancers and chronic conditions. Equally impressive, is their ability to promote gut and immune health.

 

Cordyceps Sinensis Research Summary:
-antioxidant and anti-inflammatory benefits
-help prevent or treat high blood pressure.
-compound known as cordycepin, appears able to relax blood vessels
-improves circulation and lowering blood pressure.
-relaxes airway constriction and improve quality of life measures in people with moderate to severe asthma.
-improve exercise performance.
– improve cholesterol levels and reduce weight
-able to trigger apoptosis (cell death) in breast cancer cells
– antitumor, radioprotective, antiplatelet, and antidiabetic effects.
-improved renal function and reduced nephropathy in renal transplant patients and diabetes patients with renal insufficiency undergoing coronary angiography.

Reishi Mushroom Research Summary-

-enhance immune response and decrease inflammation
-improves urinary flow in men
-reishi beta-glucans may help stop the growth and spread of cancer cells.
-reishi sterols that can act as precursors to hormones in the body
-triterpenes have blood pressure-lowering effects
-decrease high cholesterol
-stimulate cells of the immune system and immune modulation
-enhance immune response in advanced-stage cancer patients.
-antihistamine effects
-renoprotective and hepatoprotective

 

Shitake Mushroom Extract Research Summary-
-antiviral
-Immunostimulation
-Valued as an anticancer agent (antiproliferative, cytotoxic, antimutagenic, anticaries, and properties)
-Shitake lentinan is considered a biological response modifier
-Hepatoprotective
-Reduced High cholesterol
-enhanced gut immunity by upregulating interleukin (IL)-23 secretion
-Eritadenine from shiitake may exert antihypercholemic effects and regulate lipid metabolism
-antitumor effects by increasing serum IL-2 levels and TNF-α production, and by inducing apoptosis in tumor cells

Lion’s Mane Research Summary-
Neuroprotective
Nootropic (cognitive enhancer)
Anti-inflammatory
Increases NGF levels in the brain which enhance neuronal growth, regeneration and synaptic plasticity
Improves myelination, enhanced neuronal communication and nerve regeneratio
increases long-term synaptic potentiation thus improving memor
Decreases glutamatergic transmission resulting in decreased neuronal excitability and excitotoxicity
Protects neurons from endoplasmic reticulum stress
Anxiolytic (anti- stress)

Mitake Mushroom Research Summary-
treat diabetes and hypertension.
enhance immune function
treat HIV and cancer
Beta 1,6-glucan, a protein bound polysaccharide, has been identified as the active constituent
exhibited hypoglycemic effects in a few studies
inducing ovulation in patients with polycystic ovary syndrome
demonstrated antitumor effects
enhanced bone marrow colony formation
reduced doxorubicin toxicity
inhibited tumor metastasis
promoted maturation of hematopoietic cells to functionally active myeloid cells and enhanced peripheral blood leukocyte recovery following chemotoxic bone marrow
also enhanced interferon activity against bladder cancer cells and alleviated inflammation associated with inflammatory bowel disease
antileishmanial effects
ameliorate lipid metabolic disorders by modulating gut microbial phylotypes
regulating genes involved in hepatic lipid and cholesterol metabolism
immunomodulatory effects
enhance neutrophil and monocyte function in patients
Hypertension
• Immunostimulation by activating various effector cells, such as macrophages, natural killer cells, and T cells, as well as interleukin-1 and superoxide
• antidiabetic effect of alpha-glucan may be due to its effects on insulin receptors by increasing insulin sensitivity and ameliorating insulin resistance of peripheral target tissues
• exerted antidepressant effects in mice, involving activation of the α-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors, which are important mediators for the treatment of depression

 

Turkey Tail Mushroom Research Summary-

Immunostimulant
anti-tumor properties
Polysaccharide-K (PSK), a proprietary product derived from Coriolus, was developed for cancer treatment in Japan. When used as an adjuvant, PSK appears to improve survival rates in patients with gastric (1) (2) and colorectal (3) (4) (5) cancers. It may also benefit patients with esophageal cancer (27).
Immunomodulatory effects
• Cancer prevention
• Cancer treatment
• Chemotherapy side effects
• Hepatitis
• Herpes
• Immunostimulation
• Infections
• Radiation therapy side effects
• Strength and stamina

Chaga Research Summary-
demonstrated antitumor, anti-mutagenic, antiviral, antiplatelet, antidiabetic, antioxidant, and analgesic effects
immunomodulating
anti-inflammatory
pain-relieving properties (3).
anti-allergic
cognition-enhancing
antioxidant activities
anti-inflammatory effects
increased exercise endurance and biological measures related to fatigue
Antidiabetic effects have also been observed
demonstrated inhibitory and proapoptotic effects against colon, lung and liver cancer cells
exerts antitumor effects against cervical cancer cells
demonstrated selective apoptosis in tumor cells with no effects on healthy Anti-inflammatory
• Cancer treatment and prevention
• Hepatoprotective
• Immunostimulation
• antidiabetic effects are attributed to terpenoids that inhibit alpha-glucosidase
• Anti-inflammatory and pain-relieving properties may occur via inhibition of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)
• Immunomodulating effects are attributed to Th1/Th2 cytokine secretion in immune cells
• regulation of antigen-specific antibody production
• Anti-quorum sensing activity in chaga conks suggests broader anti-infection attributes beyond immunomodulatory effects
• Antifatigue effects were attributed to polysaccharides from chaga, which increased endurance and glycogen content
• Anti-inflammatory effects in animal colitis models were related to suppression of tumor necrosis factor (TNF)-alpha, iNOS, and interleukin (IL)-1beta
• Water-soluble lignin derivatives have also been identified as bioactive constituents with anticancer

Royal Sun Agaricus Research Summary
anticancer
immunostimulant effects
antitumoral activity
polysaccharides and protein polysaccharide complexes displayed antiviral activity
improves liver function in patients with hepatitis B
Immunomodulating Effect by Polysaccharide is an immunologic adjuvant
Antihyperglycemic
Antihypertriglyceridemic
Antihypercholesterolemic
Antiarteriosclerotic
antidiabetic activity
antitumor
antiviral

White Button Mushroom Research Summary-
Chemopreventive
immunomodulating activities
polysaccharides and especially beta-D-glucans bind to and inhibit the activity of aromatase, an enzyme responsible for the conversion of androgens to estrogens and which is often upregulated in breast cancer cells.
this extract may promote dendritic cell (DC) maturation, increase interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) production, and may enhance natural killer (NK) cell activity, thus amplifying both innate and T cell-mediated immune responses against cancer cells

 

Black fungus
Reliable source of prebiotics, mainly in the form of beta glucan, which enhances the immune response via gut microbiome
Hepatoprotective
anti-inflammatory
antiviral
anticoagulant
antitumor properties
multinutrient composition
Rich in Vitamin K, vital to immune health
rich in iron, as well as cellulose and a special plant collagen
Cellulose and collagen together can promote intestinal fat/food excretion, prevent constipation, and help the body to remove toxic substances (which alleviates postpartum hemorrhoids

Antioxidants

Suuggested Use

Product Information
Serving Size: 2 Capsules
Capsules Per Container: 60
Directions: Take 2 capsules daily, 20-30 minutes before a meal, with an 8 oz glass of water.

FAQ

FAQ:
Does it matter what part of the mushroom is used?
The short answer is YES! Mushroom fruiting body extracts offer a more potent and higher quality product than mycelium extracts. Concentrated fruiting body extracts contain more bioactive levels of beta-glucans and a wider array of nutritional components, compared to the mycelium.

Are there any contraindications or side effects? Even though medicinal mushrooms are generally considered completely safe to consume, we always recommend consulting your doctor before changing your supplement regiment, especially if you have any medical conditions or are currently pregnant.

Why should I consider using medicinal mushrooms? Medicinal mushrooms have many unique characteristics and uses, specific to each mushroom. Generally, medicinal mushroom have historically been used to Boost immediate and long term immune response, anti-aging constituents, enhance memory and cognitive function, improves and supports mood, elevates endurance, and disease prevention. As research and trials continue to validate clinical applications, our understanding of these powerhouse fungi also continue to grow.
How long will it take for my medicinal mushrooms to kick in? Medicinal mushrooms are classified as adaptogenic herbs which work slowly over long periods of time, so it can take up to a few weeks for their effects to make themselves known. The benefits of medicinal mushrooms are obtained through prolonged use. For best results, it’s important to take high-quality products at known effective doses.

How are mushroom extracts made?
Medicinal mushrooms are harvested, dried and ground to a fine powder and extracted using water or alcohol solvents. This process allows for the cell wall of the raw material to be broken down, leaving the beneficial compounds (beta-glucans, triterpenes, etc.) and eliminates compounds such as chitin, which our bodies do not have the proper enzymes to break down. The resulting mushroom extract is strained, concentrated and dried. These extracts are then available for formula compounding. The intricacy of this process is just one of the many reasons it’s imperative to purchase high quality products.

Research

Research:
1. Asma Ashraf Khan, Adil Gani, Firdous A.Khanday, F.A. Masoodi (2018). Biological and pharmaceutical activities of mushroom β-glucan discussed as a potential functional food ingredient. Bioactive Carbohydrates and Dietary Fibre Volume 16, October 2018, Pages 1-13 https://doi.org/10.1016/j.bcdf.2017.12.002
2. McCleary, B. V., & Draga, A. (2016). Measurement of Beta-Glucan in mushrooms and mycelial products. Journal of AOAC International, 99(2), 364–373. http://doi.org/10.5740/jaoacint.15-0289
3. Novak M, Vetvicka V (2008). Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol. 2008 Jan;5(1):47-57. doi: 10.1080/15476910802019045.
4. Sari, M., Prange, A., Lelley, J. I., & Hambitzer, R. (2017). Screening of beta-glucan contents in commercially cultivated and wild growing mushrooms. Food Chemistry, 216, 45–51.
5. Chilton, J. Nammex: Redefining Medicinal Mushrooms, 2015
6. Stengler, Mark. (2005). The Health Benefits of Medicinal Mushrooms. Basic Health Publications, Inc.
7. http://www.edinformatics.com/math_science/what_are_polysaccharides.htm
8. http://www.nammex.com/redefining-medicinal-mushrooms/
9. Huang KC. The Pharmacology of Chinese Herbs, 2nd ed. Boca Raton: CRC Press; 1999.
10. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regime: Cordyceps sinensis, Part I. J Altern Complement Med 1998;4:289-303.
11. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regime: Cordyceps sinensis, Part II. J Altern Complement Med 1998;4:429-57.
12. Xu F, et al. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplant recipients. Nephrol Dial Transplant 1995;10:142-3.
13. Huang B, et al. Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis. J Androl 2001;22:831-7.
14. Nakamura K, et al. Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice. Jpn J Pharmacol1999;79:335-41.
15. Chiu JH, et al. Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens in human hepatoma cell line HA22T/VGH cells. Am J Chin Med1998;26:59-70.
16. Li, Y. et. al. Effect of Cordyceps sinensis on erythropoiesis in mouse bone marrow. Chin Med J (Engl). 1993 Apr;106(4):313-6.
17. Huang YL, Leu SF, Liu BC, et al. In vivo stimulatory effect of Cordyceps sinensis mycelium and its fractions on reproductive functions in male mouse. Life Sci 2004 Jul 16;75(9):1051-62.
18. Wu WC, Hsiao JR, Lian YY, et al. The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol. 2007 Jun;60(1):103-11.
19. Oh JY, Baek YM, Kim SW, et al. Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma (SKN-SH) cells induced by polysaccharides-peptide complexes produced by submerged mycelial culture of an entomopathogenic fungus Cordyceps sphecocephala. J Microbiol Biotechnol. 2008 Mar;18(3):512-9.
20. Liu WC, Wang SC, Tsai ML, et al. Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine. Radiat Res. 2006 Dec;166(6):900-7.
21. Liu WC, Chuang WL, Tsai ML, et al. Cordyceps sinensis health supplement enhances recovery from taxol-induced leukopenia. Exp Biol Med (Maywood). 2008 Apr;233(4):447-55.
22. Kubo E, Yoshikawa N, Kunitomo M, et al. Inhibitory effect of Cordyceps sinensis on experimental hepatic metastasis of melanoma by suppressing tumor cell invasion.Anticancer Res. 2010 Sep;30(9):3429-33.
23. Lo HC, Hsu TH, Tu ST, Lin KC. Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin. Am J Chin Med. 2006;34(5):819-32.
24. Shi B, Wang Z, Jin H, et al. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice. Int Immunopharmacol. 2009 May;9(5):582-6.
25. Ji NF, Yao LS, Li Y, et al. Polysaccharide of Cordyceps sinensis Enhances Cisplatin Cytotoxicity in Non-Small Cell Lung Cancer H157 Cell Line. Integr Cancer Ther.2011;10(4):359-67.
26. Zhang Z, Wang X, Zhang Y, Ye G. Effect of Cordyceps sinensis on Renal Function of Patients with Chronic Allograft Nephropathy. Urol Int. 2011;86(3):298-301.
27. Cho HJ, Cho JY, Rhee MH, et al. Cordycepin (3’-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. Eur J Pharmacol. 2007 Mar 8;558(1-3):43-51.
28. Zhao K, Li Y, Zhang H. Role of dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. J Tradit Chin Med. 2013 Jun;33(3):283-6.
29. Ding C, Tian PX, Xue W, et al. Efficacy of Cordyceps sinensis in long term treatment of renal transplant patients. Front Biosci (Elite Ed). 2011 Jan 1;3:301-7.
30. Chen S, Li Z, Krochmal R, et al. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010 May;16(5):585-90.
31. Li Y, Xue WJ, Tian PX, et al. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation. Transplant Proc. 2009 Jun;41(5):1565-9.
32. Parcell AC, Smith JM, Schulthies SS, et al. Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Apr;14(2):236-42.
33. Kai Z, Yongjian L, Sheng G, et al. Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography. J Tradit Chin Med. Aug 2015;35(4):422-427.
34. Hong T, Zhang M, Fan J. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Cochrane Database Syst Rev. Oct 12 2015(10):Cd009698.
35. Wang GH, Wang LH, Wang C, et al. Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study. Medicine (Baltimore). May 2018;97(19):e0636. doi: 10.1097/md.0000000000010636
36. Chen HS, Tsai YF, Lin S, et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. Nov 1 2004;12(21):5595-5601.
37. Gao Y, Zhou S, Wen J, et al. Mechanism of the antiulcerogenic effect of Ganoderma lucidumpolysaccharides on indomethacin-induced lesions in the rat. Life Sci. Dec 27 2002;72(6):731-745.
38. Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol. Jul 2002;72(1):207-216.
39. Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. Mar 17 1997;70(6):699-705.
40. Wachtel-Galor S, Szeto YT, Tomlinson B, et al. Ganoderma lucidum (’Lingzhi’); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. Feb 2004;55(1):75-83.
41. Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum (“Lingzhi”), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. Feb 2004;91(2):263-269.
42. Gao Y, Zhou S, Jiang W, et al. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. Aug 2003;32(3):201-215.
43. Shieh YH, Liu CF, Huang YK, et al. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am J Chin Med. 2001;29(3-4):501-7.
44. Noguchi M, Kakuma T, Tomiyasu K, et al. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms. Asian J Androl. Sep 2008;10(5):777-785.
45. Hobbs C. Medicinal Mushrooms. 3rd ed. Loveland (OR): Interweave Press; 1996.
46. Tao J, Feng KY. Experimental and clinical studies on inhibitory effect of Ganoderma lucidumon platelet aggregation. J Tongji Med Univ. 1990;10(4):240-243.
47. Wang CZ, Basila D, Aung HH, et al. Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med. 2005;33(5):807-815.
48. Gill SK, Rieder MJ. Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer. Can J Clin Pharmacol. Summer 2008;15(2):e275-285.
49. Wang X, Zhao X, Li D, et al. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull. Sep 2007;30(9):1702-1706.
50. Chen NH, Liu JW, Zhong JJ. Ganoderic Acid me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Pharmacol Sci. Oct 2008;108(2):212-216.
51. Li YB, Wang R, Wu HL, et al. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells. Oncol Rep. Sep 2008;20(3):549-556.
52. Mao T, van De Water J, Keen CL, et al. Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int J Immunother 1999;15(1):13-22.
53. Chan WK, Cheung CC, Law HK, et al. Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J Hematol Oncol. 2008;1(1):9.
54. Noguchi M, Kakuma T, Tomiyasu K, et al. Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study. Asian J Androl. 2008 Jul;10(4):651-8.
55. Weng CJ, Yen GC. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010 May;27(5):361-9.
56. Kim KC, Jun HJ, Kim JS, Kim IG. Enhancement of radiation response with combined Ganoderma lucidum and Duchesnea chrysantha extracts in human leukemia HL-60 cells. Int J Mol Med. 2008 Apr;21(4):489-98.
57. Gordan JD, Chay WY, Kelley RK, et al. “And what other medications are you taking?”. J Clin Oncol. 2011 Apr 10;29(11):e288-91.
58. Yuen MF, Ip P, Ng WK, Lai CL. Hepatotoxicity due to a formulation of Ganoderma lucidum(lingzhi). J Hepatol. 2004 Oct;41(4):686-7.
59. Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai. 2007 Jan;90(1):179-81.
60. Wanachiwanawin D, Piankijagum A, Chaiprasert A, et al. Ganoderma lucidum: a cause of pseudoparasitosis. Southeast Asian J Trop Med Public Health. 2006 Nov;37(6):1099-102.
61. Zhao S, Ye G, Fu G, Cheng JX, Yang BB, Peng C. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol. 2011 May;38(5):1319-27.
62. Pillai TG, John M, Sara Thomas G. Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India. Exp Toxicol Pathol.2011 Jan;63(1-2):157-60.
63. Chu TT, Benzie IF, Lam CW, et al. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr. 2012 Apr;107(7):1017-27.
64. Jin X, Ruiz Beguerie J, Sze DM, Chan GC . Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2012 Jun 13;6:CD007731.
65. Chang CJ, Chen YY, Lu CC, et al. Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin. Innate Immun.2014 Apr;20(3):301-11.
66. Sun LX, Lin ZB, Duan XS, et al. Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. J Drug Target.2012 Aug;20(7):582-92.
67. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007;13:265-301.
68. Paterson RR. Ganoderma – a therapeutic fungal biofactory. Phytochemistry. 2006 Sep;67(18):1985-2001.
69. Liang Y, He M, Fan X, et al. An abnormal elevation of serum CA72-4 by Ganoderma lucidumspore powder. Ann Clin Lab Sci. 2013 Summer;43(3):337-40.
70. Joseph S, Sabulal B, George V, Antony KR, Janardhanan KK. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm.2011 Sep 1;61(3):335-42.
71. Jin H, Jin F, Jin JX, et al. Protective effects of Ganoderma lucidum spore on cadmium hepatotoxicity in mice. Food Chem Toxicol. 2013 Feb;52:171-5.
72. Klupp NL, Chang D, Hawke F, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;2:CD007259.
73. Ko KK, Murthee KG, Koh TH, et al. Reishi (lingzhi) ingestion mistaken for persistent Clonorchis infection. Pathology. Oct 2014;46(6):576-578.
74. Sun LX, Li WD, Lin ZB, et al. Protection against lung cancer patient plasma-induced lymphocyte suppression by Ganoderma lucidum polysaccharides. Cell Physiol Biochem.2014;33(2):289-299.
75. Oka S, Tanaka S, Yoshida S, et al. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas.Hiroshima J Med Sci. Mar 2010;59(1):1-6.
76. Yan B, Meng X, Shi J, et al. Ganoderma lucidum spore induced CA72-4 elevation in gastrointestinal cancer: a five-case report. Integr Cancer Ther. Mar 2014;13(2):161-166.
77. Klupp NL, Kiat H, Bensoussan A, et al. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep. Aug 11 2016;6:29540.
78. Jin X, Ruiz Beguerie J, Sze DM, et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. Apr 05 2016;4:Cd007731.
79. Wang C, Shi S, Chen Q, et al. Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats. Integr Cancer Ther. Sep 2018;17(3):674-683.
80. Wu K, Na K, Chen D, et al. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. Int J Oncol. Dec 2018;53(6):2356-2368.
81. Guggenheim AG, Wright KM, Zwickey HL. Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology. Integr Med (Encinitas). Feb 2014;13(1):32-44.
82. Ng ML, Yap AT. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med 2002;8(5):581-589.
83. Okamoto T, Kodoi R, Nonaka Y, et al. Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors.2004;21(1-4):407-409.
84. Ngai PH, Ng TB. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci. Nov 14 2003;73(26):3363-3374.
85. Israilides C, Kletsas D, Arapoglou D, et al. In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine 2008.
86. Akamatsu S, Watanabe A, Tamesada M, et al. Hepatoprotective effect of extracts from Lentinus edodes mycelia on dimethylnitrosamine-induced liver injury. Biol Pharm Bull.2004;27(12):1957-1960.
87. de Lima PL, Delmanto RD, Sugui MM, et al. Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res.2001;496(1-2):23-32.
88. Shouji N, Takada K, Fukushima K, Hirasawa M. Anticaries effect of a component from shiitake (an edible mushroom). Caries Res 2000;34(1):94-98.
89. deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002;60(4):640-644.
90. Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med 1998;29(5-6):305-330.
91. Suzuki K, Tanaka H, Sugawara H, et al. Chronic hypersensitivity pneumonitis induced by Shiitake mushroom spores associated with lung cancer. Intern Med 2001;40(11):1132-1135.
92. Hanada K, Hashimoto I. Flagellate mushroom (Shiitake) dermatitis and photosensitivity. Dermatology. 1998;197(3):255-257.
93. Levy AM, Kita H, Phillips SF, et al. Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998;101(5):613-620.
94. Hobbs C. Medicinal Mushrooms, 3rd ed. Loveland (CO): Interweave Press; 1996.
95. Sia GM, Candish JK. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytother Res 1999;13(2):133-7.
96. Isoda N, Eguchi Y, Nukaya H, et al. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma. Hepatogastroenterology. 2009 Mar-Apr;56(90):437-41.
97. Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res. 2009 Jul;29(7):2739-45.
98. Hazama S, Watanabe S, Ohashi M, et al. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res.2009 Jul;29(7):2611-7.
99. Shimizu K, Watanabe S, Watanabe S, et al. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology. 2009 Jan-Feb;56(89):240-4.
100. Garg S, Cockayne SE. Shiitake dermatitis diagnosed after 16 years! Arch Dermatol. 2008 Sep;144(9):1241-2.
101. Goikoetxea MJ, Fernández-Benítez M, Sanz ML. Food allergy to Shiitake (Lentinus edodes) manifested as oesophageal symptoms in a patient with probable eosinophilic oesophagitis.Allergol Immunopathol (Madr). 2009 Nov-Dec;37(6):333-4.
102. Yukawa H, Ishikawa S, Kawanishi T, Tamesada M, Tomi H. Direct cytotoxicity of Lentinula edodes mycelia extract on human hepatocellular carcinoma cell line. Biol Pharm Bull.2012;35(7):1014-21.
103. Okuno K, Uno K. Efficacy of orally administered Lentinula edodes mycelia extract for advanced gastrointestinal cancer patients undergoing cancer chemotherapy: a pilot study. Asian Pac J Cancer Prev. 2011;12(7):1671-4.
104. Ampere A, Delhaes L, Soots J, Bart F, Wallaert B. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol. 2012 Aug;50(6):654-7.
105. Chu EY, Anand D, Dawn A, Elenitsas R, Adler DJ. Shiitake dermatitis: a report of 3 cases and review of the literature. Cutis. 2013 Jun;91(6):287-90.
106. Adriano AR, Acosta ML, Azulay DR, et al. Shiitake dermatitis: the first case reported in Brazil. An Bras Dermatol. 2013 May-Jun;88(3):417-9.
107. Hamer S, Rabindranathnambi R. A wide-spread flagellate dermatitis. BMJ Case Rep. 2013 Jan 3;2013.
108. Wang AS, Barr KL, Jagdeo J. Shiitake mushroom-induced flagellate erythema: A striking case and review of the literature. Dermatol Online J. 2013 Apr 15;19(4):5.
109. Kusumoto M, Koganemaru M, Nakayama G, Iwamoto R. Dietary small bowel obstruction.BMJ Case Rep. 2013 Jan 25;2013.
110. Chandra LC, Traoré D, French C, et al. White button, portabella, and shiitake mushroom supplementation up-regulates interleukin-23 secretion in acute dextran sodium sulfate colitis C57BL/6 mice and murine macrophage J.744.1 cell line. Nutr Res. 2013 May;33(5):388-96.
111. Handayani D, Meyer BJ, Chen J, et al. A high-dose shiitake mushroom increases hepatic accumulation of triacylglycerol in rats fed a high-fat diet: underlying mechanism. Nutrients.2014 Feb 12;6(2):650-62.
112. Rincão VP, Yamamoto KA, Ricardo NM, et al. Polysaccharide and extracts from Lentinula edodes: structural features and antiviral activity. Virol J. 2012 Feb 15;9:37.
113. Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A Polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through upregulation of the Th1 immune reaction. J Agric Food Chem. 2014 Mar 19;62(11):2384-91.
114. Wang KP, Zhang QL, Liu Y, Wang J, Cheng Y, Zhang Y. Structure and inducing tumor cell apoptosis activity of polysaccharides isolated from Lentinus edodes. J Agric Food Chem.2013 Oct 16;61(41):9849-58.
115. Isoda N, Eguchi Y, Nukaya H, et al. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma. Hepatogastroenterology. Mar-Apr 2009;56(90):437-441.
116. Oba K, Kobayashi M, Matsui T, et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res. Jul 2009;29(7):2739-2745.
117. Shimizu K, Watanabe S, Watanabe S, et al. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology. Jan-Feb 2009;56(89):240-244.
118. Sunagawa M, Isogai M, Harada T, et al. Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case. Surg Today. Jan 2014;44(1):171-174.
119. Matsuhisa K, Yamane S, Okamoto T, et al. Anti-HCV effect of Lentinula edodes mycelia solid culture extracts and low-molecular-weight lignin. Biochem Biophys Res Commun. Jun 19 2015;462(1):52-57.
120. Yang H, Hwang I, Kim S, et al. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Exp Ther Med. Dec 2013;6(6):1409-1413.
121. Wang J, Zhong M, Liu B, et al. Expression and functional analysis of novel molecule – Latcripin-13 domain from Lentinula edodes C91-3 produced in prokaryotic expression system. Gene. Jan 25 2015;555(2):469-475.
122. Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. J Am Coll Nutr. Apr 11 2015:1-10.
123. Mendonca CN, Silva PM, Avelleira JC, et al. Shiitake dermatitis. An Bras Dermatol. Mar-Apr 2015;90(2):276-278.
124. Boels D, Landreau A, Bruneau C, et al. Shiitake dermatitis recorded by French Poison Control Centers – new case series with clinical observations. Clin Toxicol (Phila). Jul 2014;52(6):625-628.
125. Corazza M, Zauli S, Ricci M, et al. Shiitake dermatitis: toxic or allergic reaction? J Eur Acad Dermatol Venereol. Jul 2015;29(7):1449-1451.
126. Hiernickel C, Metz S, Elsner P. Shiitake dermatitis: an impressive case report. J Dtsch Dermatol Ges. May 2015;13(5):455-456.
127. Hamer SE, Kulkarni K, Cohen SN. Shiitake dermatitis with oral ulceration and pustules. Clin Exp Dermatol. Apr 2015;40(3):332-333.
128. Ade R, Sukut C, Wiser HJ, et al. Shiitake dermatitis demonstrating Koebner phenomenon. Int J Dermatol. May 2015;54(5):e179-181.
129. Tanigawa K, Itoh Y, Kobayashi Y. Improvement of QOL and Immunological Function With Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study. Altern Ther Health Med. 2016 Jul;22(4):36-42.
130. Luber AJ, Ackerman LS. Flagellate shiitake mushroom dermatitis. Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt7rm57553.
131.
132. Hobbs C. Medicinal Mushrooms, 3rd ed. Loveland (CO): Interweave Press; 1996.
133. Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by beta glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull 1987;35:262-70.
134. Kubo K, Aoki H. Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa(Maitake). Biol Pharm Bull 1994;17:1106-10.
135. Horio H, Ohtsuru M. Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. J Nutr Sci Vitaminol 2001;47:57-63.
136. Kodama N, Komuta K, Nanba H. Can Maitake MD-fraction aid cancer patients? Altern Med Rev 2002;7:236-9.
137. Miura NN. Blood clearance of (1—>3)-beta-D-glucan in MRL lpr/lpr mice. FEMS Immunol Med Microbiol 1996;13:51-7.
138. Ohno N, et al. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull 1986;34:1709-1715.
139. Nanba H, Kubo K. Maitake D-fraction: Healing and preventive potential for cancer. J Orthomolecular Med 1997;12:43-9.
140. Konno S, et al. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet Med 2001 Dec;18(12):1010
141. Yamada Y, et al. Antitumor effect of orally administered extracts from fruit body of Grifola frondosa (maitake). Chemotherapy 1990;38:790-6.
142. Lin H, et al. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 2004 Jan;4(1):91-9.
143. Hong L, Xun M, Wutong W. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. Pharm Pharmacol. 2007 Apr;59(4):575-82.
144. Masuda Y, Murata Y, Hayashi M, Nanba H. Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells. Biol Pharm Bull 2008 Jun;31(6):1104-8.
145. Deng G, Lin H, Seidman A, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. 2009 Sep;135(9):1215-21
146. Harada N, Kodama N, Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett.2003;192(2):181-7.
147. Shomori K, Yamamoto M, Arifuku I, Teramachi K, Ito H. Antitumor effects of a water-soluble extract from Maitake (Grifola frondosa) on human gastric cancer cell lines. Oncol Rep. 2009 Sep;22(3):615-20.
148. Lin H, de Stanchina E, Zhou XK, et al. Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity. Cancer Immunol Immunother. 2010 Jun;59(6):885-97.
149. Louie B, Rajamahanty S, Won J, Choudhury M, Konno S. Synergistic potentiation of interferon activity with maitake mushroom d-fraction on bladder cancer cells. BJU Int. 2010 Apr;105(7):1011-5.
150. Lee JS, Park SY, Thapa D, et al. Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling. Exp Mol Med. 2010 Feb 28;42(2):143-54.
151. Masuda Y, Ito K, Konishi M, Nanba H. A polysaccharide extracted from Grifola frondosaenhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Cancer Immunol Immunother. 2010 Oct;59(10):1531-41.
152. Hanselin MR, Vande Griend JP, Linnebur SA. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother. 2010 Jan;44(1):223-4.
153. Chen JT, Tominaga K, Sato Y, Anzai H, Matsuoka R. Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: a possible monotherapy and a combination therapy after failure with first-line clomiphene citrate. J Altern Complement Med. 2010 Dec;16(12):1295-9.
154. Soares R, Meireles M, Rocha A, et al. Maitake (D fraction) mushroom extract induces apoptosis in breast cancer cells by BAK-1 gene activation.J Med Food. 2011 Jun;14(6):563-72.
155. Fang J, Wang Y, Lv X, et al. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconj J. 2012 Aug;29(5-6):365-77.
156. Wesa KM, Cunningham-Rundles S, Klimek VM, et al. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother. (2015) 64:237–247 DOI 10.1007/s00262-014-1628-6
157. Roldan-Deamicis A, Alonso E, Brie B, Braico DA, Balogh GA. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice. Cancer Med. 2016 Sep;5(9):2427-41.
158. Zhang Y, Sun D, Meng Q, Guo W, Chen Q, Zhang Y. Grifola frondosa polysaccharides induce breast cancer cell apoptosis via the mitochondrial-dependent apoptotic pathway. Int J Mol Med. 2017 Oct;40(4):1089-1095.
159. Masuda Y, Nakayama Y, Tanaka A, Naito K, Konishi M. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.PLoS One. 2017 Mar 9;12(3):e0173621.
160. Bao H, Ran P, Sun L et al. Griflola frondosa (GF) produces significant antidepressant effects involving AMPA receptor activation in mice. Pharm Biol. 2017 Dec;55(1):299-305.
161. Mao G, Li Q, Deng C, et al. The synergism and attenuation effect of Selenium (Se)-enriched Grifola frondosa (Se)-polysaccharide on 5-Fluorouracil (5-Fu) in Heps-bearing mice. Int J Biol Macromol. 2018 Feb;107(Pt B):2211-2216.
162. Zhao F, Zhao J, Song L, Zhang YQ, Guo Z, Yang KH. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa. Apoptosis. 2017 Nov;22(11):1461-1472.
163. Sultana SS, Ghosh J, Chakraborty S, et al. Selective in vitro inhibition of Leishmania donovani by a semi-purified fraction of wild mushroom Grifola frondosa. Exp Parasitol. 2018 Sep;192:73-84.
164. Meng M, Guo M, Feng C, Wang R, Cheng D, Wang C. Water-soluble polysaccharides from Grifola Frondosa fruiting bodies protect against immunosuppression in cyclophosphamide-induced mice via JAK2/STAT3/SOCS signal transduction pathways. Food Funct. 2019 Aug 1;10(8):4998-5007.
165. Li L, Guo WL, Zhang W, et al. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats. Food Funct. 2019 May 22;10(5):2560-2572.

1. Youn MJ, Kim JK, Park SY, et al. Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol. Jan 28 2008;14(4):511-517.
2. Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus.Peptides. Jun 2006;27(6):1173-1178.
3. Park YM, Won JH, Kim YH, et al. In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol. Oct 3 2005;101(1-3):120-128.
4. Sun JE, Ao ZH, Lu ZM, et al. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J Ethnopharmacol. Jun 19 2008;118(1):7-13.
5. Lee SH, Hwang HS, Yun JW. Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res. Apr 15 2009.
6. Zhong XH, Ren K, Lu SJ, Yang SY, Sun DZ. Progress of research on Inonotus obliquus. Chin J Integr Med. Apr 2009;15(2):156-160.
7. Youn MJ, Kim JK, Park SY, et al. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells. J Ethnopharmacol. Jan 21 2009;121(2):221-228.
8. Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors. 2007;31(3-4):191-200.
9. Ham SS, Kim SH, Moon SY, et al. Antimutagenic effects of subfractions of Chaga mushroom (Inonotus obliquus) extract. Mutat Res. Jan 10 2009;672(1):55-59.
10. Caifa Chen WZ, Gao X, Xiang X, et al. Aqueous Extract of Inonotus obliquus (Fr.) Pilat (Hymenochaetaceae) Significantly Inhibits the Growth of Sarcoma 180 by Inducing Apoptosis. Am J Pharmacol Toxicol. 2007. 2(1):10-17.
11. Shashkina MY, Shashkin PN, Sergeev AV. Chemical and Medicobiological Properties of Chaga (Review). Pharmaceutical Chemistry Journal 2006. 40(10):560-568.
12. Glamoclija J, Ciric A, Nikolic M, et al. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal “mushroom”. J Ethnopharmacol. Mar 13 2015;162:323-332.
13. Ning X, Luo Q, Li C, et al. Inhibitory effects of a polysaccharide extract from the Chaga medicinal mushroom, Inonotus obliquus (higher Basidiomycetes), on the proliferation of human neurogliocytoma cells. Int J Med Mushrooms. 2014;16(1):29-36.
14. Pan HH, Yu XT, Li T, et al. Aqueous extract from a Chaga medicinal mushroom, Inonotus obliquus (higher Basidiomycetes), prevents herpes simplex virus entry through inhibition of viral-induced membrane fusion. Int J Med Mushrooms. 2013;15(1):29-38.
15. Ying YM, Zhang LY, Zhang X, et al. Terpenoids with alpha-glucosidase inhibitory activity from the submerged culture of Inonotus obliquus. Phytochemistry. Dec 2014;108:171-176.
16. Ko SK, Jin M, Pyo MY. Inonotus obliquus extracts suppress antigen-specific IgE production through the modulation of Th1/Th2 cytokines in ovalbumin-sensitized mice. J Ethnopharmacol. Oct 11 2011;137(3):1077-1082.
17. Yoon TJ, Lee SJ, Kim EY, et al. Inhibitory effect of chaga mushroom extract on compound 48/80-induced anaphylactic shock and IgE production in mice. Int Immunopharmacol. Apr 2013;15(4):666-670.
18. Giridharan VV, Thandavarayan RA, Konishi T. Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus – a medicinal mushroom. Food Funct.Jun 2011;2(6):320-327.
19. Mishra SK, Kang JH, Kim DK, et al. Orally administered aqueous extract of Inonotus obliquusameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. J Ethnopharmacol. Sep 28 2012;143(2):524-532.
20. Yue Z, Xiuhong Z, Shuyan Y, et al. Effect of Inonotus Obliquus Polysaccharides on physical fatigue in mice. J Tradit Chin Med. Aug 2015;35(4):468-472.
21. Kang JH, Jang JE, Mishra SK, et al. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the beta-catenin pathway in colorectal cancer. J Ethnopharmacol. Sep 15 2015;173:303-312.
22. Lee HS, Kim EJ, Kim SH. Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells. Nutr Res Pract. Apr 2015;9(2):111-116.
23. Zhao LW, Zhong XH, Yang SY, et al. Inotodiol inhabits proliferation and induces apoptosis through modulating expression of cyclinE, p27, bcl-2, and bax in human cervical cancer HeLa cells. Asian Pac J Cancer Prev. 2014;15(7):3195-3199.
24. Kikuchi Y, Seta K, Ogawa Y, et al. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. Jun 2014;81(6):440-444.
25. Sun Y, Yin T, Chen XH, et al. In vitro antitumor activity and structure characterization of ethanol extracts from wild and cultivated Chaga medicinal mushroom, Inonotus obliquus(Pers.:Fr.) Pilat (Aphyllophoromycetideae). Int J Med Mushrooms. 2011;13(2):121-130.
26. Wang Q, Mu H, Zhang L, et al. Characterization of two water-soluble lignin metabolites with antiproliferative activities from Inonotus obliquus. Int J Biol Macromol. Mar 2015;74:507-514.
27. Wang J, Hu W, Li L, et al. Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes. PLoS One. 2017;12(6):e0180476. doi: 10.1371/journal.pone.0180476
28. Baek J, Roh HS, Baek KH, et al. Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J Ethnopharmacol. Oct 5 2018;224:63-75.

https://www.ncbi.nlm.nih.gov/pubmed/11739882
References
1. C. U. Lima, C. O. Cordova, O. D. Nóbrega, S. S. Funghetto, and M. G. Karnikowski, “Does the Agaricus blazei Murill mushroom have properties that affect the immune system? an integrative review,” Journal of Medicinal Food, vol. 14, no. 1-2, pp. 2–8, 2011. View at: Publisher Site | Google Scholar
2. M. L. C. Gonzaga, N. M. P. S. Ricardo, F. Heatley, and S. D. A. Soares, “Isolation and characterization of polysaccharides from Agaricus blazei Murill,” Carbohydrate Polymers, vol. 60, no. 1, pp. 43–49, 2005. View at: Publisher Site | Google Scholar
3. H. Kawagishi, T. Kanao, R. Inagaki et al., “Formolysis of a potent antitumor (1 → 6)-β-d-glucan-protein complex from Agaricus blazei fruiting bodies and antitumor activity of the resulting products,” Carbohydrate Polymers, vol. 12, no. 4, pp. 393–403, 1990. View at: Google Scholar
4. C.-H. Shu and B.-J. Wen, “Enhanced shear protection and increased production of an anti-tumor polysaccharide by Agaricus blazei in xanthan-supplemented cultures,” Biotechnology Letters, vol. 25, no. 11, pp. 873–876, 2003. View at: Publisher Site | Google Scholar
5. M. L. Gonzaga, D. P. Bezerra, A. P. Alves et al., “In vivo growth-inhibition of Sarcoma 180 by an α-(1 → 4)-glucan-β-(1 → 6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill,” Journal of Natural Medicines, vol. 63, no. 1, pp. 32–40, 2009. View at: Publisher Site | Google Scholar
6. T. Mizuno, T. Hagiwara, T. Nakamura et al., “Antitumor activity and some properties of water-soluble polysaccharides from ‘Himematsutake’, the fruiting body of Agaricus blazei Murill,” Agricultural and Biological Chemistry, vol. 54, pp. 2889–2896, 1990. View at: Publisher Site | Google Scholar
7. M. Mizuno, K.-I. Minato, H. Ito, M. Kawade, H. Terai, and H. Tsuchida, “Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill,” Biochemistry and Molecular Biology International, vol. 47, no. 4, pp. 707–714, 1999. View at: Google Scholar
8. M. Endo, H. Beppu, H. Akiyama et al., “Agaritine purified from Agaricus blazeiMurrill exerts anti-tumor activity against leukemic cells,” Biochimica et Biophysica Acta, vol. 1800, no. 7, pp. 669–673, 2010. View at: Publisher Site | Google Scholar
9. H. Akiyama, M. Endo, T. Matsui et al., “Agaritine from Agaricus blazei Murrill induces apoptosis in the leukemic cell line U937,” Biochimica et Biophysica Acta, vol. 1810, no. 5, pp. 519–525, 2011. View at: Publisher Site | Google Scholar
10. T. Takaku, Y. Kimura, and H. Okuda, “Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action,” Journal of Nutrition, vol. 131, no. 5, pp. 1409–1413, 2001. View at: Google Scholar
11. F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008. View at: Publisher Site | Google Scholar
12. L. C. Faccin, F. Benati, V. P. Rincão et al., “Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensisagainst poliovirus type 1,” Letters in Applied Microbiology, vol. 45, no. 1, pp. 24–28, 2007. View at: Publisher Site | Google Scholar
13. F. T. G. de Sousa Cardozo, C. M. Camelini, A. Mascarello et al., “Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia,” Antiviral Research, vol. 92, no. 1, pp. 108–114, 2011. View at: Publisher Site | Google Scholar
14. M.-F. Wu, Y.-M. Hsu, M.-C. Tang et al., “Agaricus blazei Murill extract abrogates CCl14-induced liver injury in rats,” In Vivo, vol. 25, no. 1, pp. 35–40, 2011. View at: Google Scholar
15. J.-B. Chang, M.-F. Wu, Y.-Y. Yang et al., “Carbon tetrachloride-induced hepatotoxicity and its amelioration by Agaricus blazei Murrill extract in a mouse model,” In Vivo, vol. 25, no. 6, pp. 971–976, 2011. View at: Google Scholar
16. L. Chen, H. J. Shao, and Y. B. Su, “Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses,” International Immunopharmacology, vol. 4, no. 3, pp. 403–409, 2004. View at: Publisher Site | Google Scholar
17. C.-H. Hsu, K.-C. Hwang, Y.-H. Chiang, and P. Chou, “The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B,” Journal of Alternative and Complementary Medicine, vol. 14, no. 3, pp. 299–301, 2008. View at: Publisher Site | Google Scholar
18. B. Grinde, G. Hetland, and E. Johnson, “Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection,” International Immunopharmacology, vol. 6, no. 8, pp. 1311–1314, 2006. View at: Publisher Site | Google Scholar
19. H. Inuzuka and T. Yoshida, “Clinical utility of ABCL (Agalicus MushroomExtract) treatment for C-type hepatitis,” Japanese Pharmacology and Therapeutics, vol. 30, no. 2, pp. 103–107, 2002. View at: Google Scholar
20. H. Mukai, T. Watanabe, M. Ando, and N. Katsumata, “An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients,” Japanese Journal of Clinical Oncology, vol. 36, no. 12, pp. 808–810, 2006. View at: Publisher Site | Google Scholar
21. V. E. C. Ooi and F. Liu, “Immunomodulation and anti-cancer activity of polysaccharide-protein complexes,” Current Medicinal Chemistry, vol. 7, no. 7, pp. 715–729, 2000. View at: Google Scholar
22. M. Mizuno, M. Morimoto, K.-I. Minato, and H. Tsuchida, “Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice,” Bioscience, Biotechnology and Biochemistry, vol. 62, no. 3, pp. 434–437, 1998. View at: Google Scholar
23. J. G. Lin, M. J. Fan, N. Y. Tang et al., “An extract of Agaricus blazei Murill administered orally promotes immune responses in murine leukemia BALB/c mice in vivo,” Integrative Cancer Therapies, vol. 11, pp. 29–36, 2012. View at: Publisher Site | Google Scholar
24. C. U. J. O. Lima, V. C. Souza, M. C. Morita, M. D. Chiarello, and M. G. de Oliveira Karnikowski, “Agaricus blazei Murrill and inflammatory mediators in elderly women: a randomized clinical trial,” Scandinavian Journal of Immunology, vol. 75, no. 3, pp. 336–341, 2012. View at: Publisher Site | Google Scholar
25. Y.-W. Kim, K.-H. Kim, H.-J. Choi, and D.-S. Lee, “Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei,” Biotechnology Letters, vol. 27, no. 7, pp. 483–487, 2005. View at: Publisher Site | Google Scholar
26. T. W. Oh, Y. A. Kim, W. J. Jang et al., “Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats,” Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 4113–4119, 2010. View at: Publisher Site | Google Scholar
27. F. C. Di Naso, R. N. de Mello, S. Bona et al., “Effect of Agaricus blazei Murill on the pulmonary tissue of animals with streptozotocin-induced diabetes,” Experimental Diabetes Research, vol. 2010, p. 543926, 2010. View at: Google Scholar
28. A. Niwa, T. Tajiri, and H. Higashino, “Ipomoea batatas and Agarics blazeiameliorate diabetic disorders with therapeutic antioxidant potential in streptozotocin-induced diabetic rats,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 3, pp. 194–202, 2011. View at: Publisher Site | Google Scholar
29. D. G. Valadares, M. C. Duarte, J. S. Oliveira et al., “Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species,” Parasitology International, vol. 60, no. 4, pp. 357–363, 2011. View at: Publisher Site | Google Scholar
30. D. G. Valadares, M. C. Duarte, L. Ramírez et al., “Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis,” Parasitology Research, vol. 111, pp. 1807–1816, 2012. View at: Google Scholar
31. D. G. Valadares, M. C. Duarte, L. Ramírez et al., “Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis,” Experimental Parasitology, vol. 132, no. 2, pp. 228–236, 2012. View at: Publisher Site | Google Scholar
32. S. L. Friedman, “Seminars in medicine of the Beth Isreal Hospital, Boston, the cellular basis of hepatic fibrosis, mechanismas and treatment strategies,” The New England Journal of Medicine, vol. 328, no. 25, pp. 1828–1835, 1993. View at: Publisher Site | Google Scholar
33. A. M. Gressner, “Cytokines and cellular crosstalk involved in the activation of fat-storing cells,” Journal of Hepatology, vol. 22, no. 2, pp. 28–36, 1995. View at: Google Scholar
34. C. S. Lieber, “Prevention and treatment of liver fibrosis based on pathogenesis,” Alcoholism, vol. 23, no. 5, pp. 944–949, 1999. View at: Google Scholar
35. W. J. Brattin, E. A. Glende Jr., and R. O. Recknagel, “Pathological mechanisms in carbon tetrachloride hepatotoxicity,” Journal of Free Radicals in Biology and Medicine, vol. 1, no. 1, pp. 27–38, 1985. View at: Google Scholar
36. R. A. Boulton, M. R. Alison, M. Golding, C. Selden, and H. J. F. Hodgson, “Augmentation of the early phase of liver regeneration after 70% partial hepatectomy in rats following selective Kupffer cell depletion,” Journal of Hepatology, vol. 29, no. 2, pp. 271–280, 1998. View at: Publisher Site | Google Scholar
37. H. H. Song, H. S. Chae, S. R. Oh, H. K. Lee, and Y. W. Chin, “Anti-Inflammatory and anti-allergic effect of Agaricus blazei extract in bone marrow-derived mast cells,” The American Journal of Chinese Medicine, vol. 40, no. 5, pp. 1073–1084, 2012. View at: Publisher Site | Google Scholar
38. J. L. Gonçalves, E. H. Roma, A. C. Gomes-Santos et al., “Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development,” European Journal of Nutrition, vol. 51, pp. 927–937, 2012. View at: Google Scholar
39. Z. Sui, R. Yang, B. Liu et al., “Chemical analysis of Agaricus blazeipolysaccharides and effect of the polysaccharides on IL-1β mRNA expression in skin of burn wound-treated rats,” International Journal of Biological Macromolecules, vol. 47, no. 2, pp. 155–157, 2010. View at: Publisher Site | Google Scholar
40. T. Watanabe, A. Kawashita, S. Ishi et al., “Antihypertensive effect of γ-aminobutyric acid-enriched Agaricus blazei on mild hypertensive human subjects,” Nippon Shokuhin Kagaku Kogaku Kaishi, vol. 50, no. 4, pp. 167–173, 2003.

2 reviews for Thrive – Mushroom Immune Complex

  1. Eddie B

    A friend encouraged me to take a mushroom supplement. After searching many listings I found that this complex has a lot of beneficial mushrooms.

  2. Travis Witmore

    After listening to Joe Rogan’s podcast, I take a mushroom complex daily. This is the best one I have found from a reputable company.

Add a review

Your email address will not be published.